|
Volumn 21, Issue 4, 2013, Pages 371-374
|
Impact of clinical pharmacist on cost of drug therapy in the ICU
|
Author keywords
Clinical pharmacist; Cost saving; Drugs consumption; Intensive care unit
|
Indexed keywords
ACICLOVIR;
ADRENALIN;
AMIKACIN;
ANTIINFECTIVE AGENT;
AZITHROMYCIN;
CARDIOVASCULAR AGENT;
CEFEPIME;
CEFOTAXIME;
CEFTAZIDIME;
CEFTRIAXONE;
CILASTATIN;
DOBUTAMINE;
DOPAMINE;
FLUCLOXACILLIN;
FLUCONAZOLE;
FUROSEMIDE;
GENTAMICIN;
GLYCERYL TRINITRATE;
HEPARIN;
HYDRALAZINE;
IMIPENEM;
LABETALOL;
METRONIDAZOLE;
NIMODIPINE;
PENICILLIN G;
PROSTAGLANDIN E1;
TAZOBACTAM;
TINZAPARIN;
UNINDEXED DRUG;
VANCOMYCIN;
ARTICLE;
CLINICAL PHARMACY;
CLINICAL PRACTICE;
COST CONTROL;
DRUG COST;
DRUG USE;
HEALTH CARE COST;
HOSPITAL ADMISSION;
HUMAN;
INTENSIVE CARE UNIT;
JORDAN;
MEDICAL SERVICE;
PHARMACIST;
WARD;
|
EID: 84884593953
PISSN: 13190164
EISSN: None
Source Type: Journal
DOI: 10.1016/j.jsps.2012.12.004 Document Type: Article |
Times cited : (22)
|
References (6)
|